Powered by

EuroBiotech—More Articles of Note

Jan 17, 2019 - FierceBiotech

> BioMed X and Boehringer Ingelheim added another strand to their multiyear collaboration. The new project will support research into targets for early interventions into psychiatric diseases. Release

> Nanobiotix unveiled plans to list its stock in the U.S. Statement

> Boehringer Ingelheim teamed up with Bioharmony Therapeutics to develop bacteriophage lysins to treat multidrug resistant infections. Release

> Sanofi secured access to Biomunex Pharmaceuticals' techn...